Transforming Diagnostics in Sub-Saharan Africa
Our mission is to save the lives of young children and adults by leveraging our intellectual property and know-how to enable precise and rapid diagnosis of inherited blood disorders, infectious diseases and early-stage cancer in sub-Saharan Africa.
In sub-Saharan Africa, many diseases that can be easily cured or well controlled with affordable therapies are currently not diagnosed. Our mission is to help establish a diagnostic testing and screening facility in sub-Saharan Africa starting with Tanzania to improve healthcare screening and clinical care in this key underserved patient population.
Sickle Cell disease is the most common inherited monogenic disease world-wide affecting 3% of births in Tanzania. Undiagnosed, 95% of children die within the first 5 years of life
The East African region is endemic with multiple zoonotic diseases and is a hotspot for emerging infectious zoonotic diseases. Further, widespread and unregulated antibiotic use has led to the rapid emergence of resistance. We partner with ONT to enable rapid, affordable pathogen surveillance sequencing to identify new outbreaks and resistance development
We will enable government agencies and local scientists to harness the power of the African genome for drug development and pharmacogenomics globally
If diagnosed early, over 90% of patients with cancer can be cured in-country and treatment costs are a fraction of those for late-stage cancer. We apply our know-how to cancer screening from a simple blood draw
Our mission is to enable a new generation of locally delivered accurate, rapid and affordable clinical testing in sub-Saharan Africa.
“In sub-Saharan Africa many diseases that could be easily cured or well controlled with affordable therapies are currently not diagnosed”
– Dr Anna Schuh
Case study: Early diagnosis of lymphoma in children and young adults in sub-Saharan Africa